RUBY
Rubius Therapeutics, Inc
RUBY
RUBY
Delisted
RUBY was delisted on the 6th of March, 2023.
72 hedge funds and large institutions have $66.6M invested in Rubius Therapeutics, Inc in 2022 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 19 increasing their positions, 28 reducing their positions, and 58 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
72
Holders Change
-45
Holders Change %
-38.46%
% of All Funds
1.22%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
16
Increased
19
Reduced
28
Closed
58
Calls
$34K
Puts
$1K
Net Calls
+$33K
Net Calls Change
-$4.19M
Top Buyers
| 1 |
1
Renaissance Technologies
New York
|
$703K |
| 2 |
2
Acadian Asset Management
Boston,
Massachusetts
|
$345K |
| 3 |
3
Millennium Management
New York
|
$777K |
| 4 |
4
Two Sigma Investments
New York
|
$564K |
| 5 |
5
Two Sigma Advisers
New York
|
$479K |
